HPV Carcinomas in Immunocompromised Patients

HPV Carcinomas in Immunocompromised Patients

Human papillomavirus (HPV) infection is the most common sexually transmitted disease worldwide and can result in pre-malignancies or overt malignancies of the skin and mucosal surfaces. HPV-related illnesses are an important personal and public health problem causing physical, mental, sexual and financial detriments. Moreover, this set of malignancies severely affects the immunosuppressed popul...

HPV infection and HPV-associated neoplasia in immunocompromised women

HPV vaccines in immunocompromised women and men

HIV-positive as well as other immunocompromised women and men have increased risk of human papillomavirus (HPV)-associated nogenital and oral cancers. The effectiveness of a HPV vaccine to reduce the incidence of these tumors in immunocompromised individuals ay depend on several factors, including the effects of immunocompromise on the response to vaccination, the extent of prior infection ith ...

HPV detection in oral carcinomas Detecção do HPV em carcinomas orais

y ke words abstract The authors set out in this study to verify the presence of lowand high-risk DNA of human papillomavirus (HPV) in oral cancer by means of the hybrid capture Digene® test (São Paulo-SP, Brazil) in smears from exfoliative cytology and also to compare the findings with those of conventional light microscopy (hematoxylin-eosin (HE)/Papanicolaou). Forty individuals gave their wri...

Etiologic Agents of Candidemia in Pediatric Immunocompromised Patients

Abstract Background: Candidemia is the main cause of fungal nosocomial bloodstream infections and is related to meaningful mortality specially, in pediatrics. Mortality rate range from 5% to 71%, and it can reach as high as 81%. Delays in beginning of treatment have also been linked to intensified mortality. The epidemiology of Candida infection is changing from region to region. Regiona...